Justice Department materials list an April 5, 2027 trial before Judge Aileen M. Cannon in a federal case alleging that school-based cardiovascular testing produced false claims, unreliable certifications, and more than $13 million in insurer payments
WASHINGTON, DC — A federal trial for Texas cardiologist Jason Finkelstein is scheduled to begin April 5, 2027, in West Palm Beach, where jurors may hear evidence about an alleged nationwide healthcare fraud operation built around cardiovascular testing performed on student athletes.
The proceeding is assigned to Judge Aileen M. Cannon in the Southern District of Florida, although the scheduled date remains subject to later court orders, pretrial rulings, case-management decisions, and any lawful resolution reached before a jury is selected.
Finkelstein has pleaded not guilty and remains presumed innocent, requiring prosecutors to prove every charged element beyond a reasonable doubt rather than relying upon the scale of the allegations, the government’s enforcement announcement, or the emotional gravity surrounding one athlete’s death.
The Justice Department’s official case page identifies docket number 26-cr-80123 and assigns the matter to the Paul G. Rogers Federal Building and United States Courthouse on Clematis Street in downtown West Palm Beach, Florida, for scheduled proceedings.
The April Trial Date Follows Two Preliminary Court Milestones
Before the scheduled trial, Justice Department materials list a September 16, 2026 status conference at 1:30 p.m., giving the court and lawyers an opportunity to address discovery, anticipated motions, scheduling complications, and the practical condition of trial preparations.
A calendar call is then scheduled for March 30, 2027, at 1:45 p.m., only six days before trial, when the court can evaluate whether the parties are ready, identify unresolved issues, and confirm how jury selection will proceed.
Those dates create a visible framework for a case expected to involve extensive electronic claims data, diagnostic images, school communications, medical records, corporate documents, payment trails, insurance policies, and expert testimony spanning several specialized areas.
They do not guarantee that opening statements will occur on April 5, because federal criminal schedules often change when discovery grows, motions require hearings, experts need additional preparation, or the court adjusts its calendar for competing proceedings.
For affected athletes, families, schools, insurers, and potential witnesses, the published timetable nevertheless establishes the clearest current indication of when the government’s allegations may finally move from charging documents into an adversarial public trial before jurors.
West Palm Beach Connects the Alleged Scheme to South Florida
Although Finkelstein lived and practiced in Texas, prosecutors allege that he served as medical director of an unnamed cardiovascular testing company headquartered in Boca Raton, where two unidentified co-conspirators allegedly managed ownership, operations, marketing, and other business functions.
The indictment says conduct occurred in Palm Beach County and elsewhere, creating the jurisdictional connection that brought the federal prosecution to the Southern District of Florida rather than limiting the case to Finkelstein’s professional associations in Tarrant County, Texas.
Prosecutors allege the Florida company sent sonographers to college campuses across the country, while Finkelstein’s two Texas entities, Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA, submitted claims arising from those encounters.
The government further says an outside medical billing software company transmitted claims through interstate communications, an allegation supporting the wire-fraud objective included within the conspiracy count even though the indictment does not charge a separate substantive wire-fraud offense.
Venue may appear procedural beside the medical and financial accusations, yet it determines where jurors are drawn, where evidence is presented, which appellate court reviews contested rulings, and how witnesses from distant states must participate.
Jurors Could Consider Four Federal Counts
Count One alleges conspiracy to commit healthcare fraud and wire fraud, requiring proof that Finkelstein knowingly and willfully joined an agreement pursuing unlawful objectives rather than merely working with people who independently committed errors or misconduct.
Counts Two through Four allege substantive healthcare fraud involving specified claims, including two abdominal aorta ultrasound transactions and one cardiovascular testing panel connected with the student athlete identified in the indictment by the initials KF.
The three identified claims carried billed amounts of approximately $150, $150, and $975, figures far smaller than the alleged enterprise total but important because substantive fraud counts require evidence tied to particular executions or attempted executions of the claimed scheme.
Prosecutors must establish that material representations were knowingly false and connected with payment for healthcare benefits, while the defense may dispute authorship, knowledge, medical necessity, coding decisions, platform records, payer requirements, or the significance of an identified inaccuracy.
The conspiracy theory lets the government present a broader course of conduct from approximately January 2019 through December 2025, but the prosecution must still show that Finkelstein knowingly embraced the unlawful agreement described in the indictment.
School Athlete Screenings Form the Center of the Government’s Theory
Federal prosecutors allege the enterprise marketed cardiovascular testing to college athletic departments by emphasizing sudden cardiac arrest, presenting examinations as protection against a rare but devastating event capable of ending a young athlete’s life without warning.
According to the indictment, some students were told the testing was mandatory for participation, while the services were promoted as carrying no direct cost, circumstances that allegedly helped the company assemble large groups of insured athletes at scheduled campus events.
The government says athletic directors and other referral sources received or were offered checks, wire transfers, gift cards, or other inducements, although each alleged payment and Finkelstein’s knowledge of any arrangement will require proof through admissible evidence.
Almost every athlete allegedly received the same six-test panel, including electrocardiograms, echocardiograms, and several vascular ultrasound examinations, without an individualized physician assessment to determine whether symptoms, history, measurements, or other clinical findings supported each diagnostic procedure.
Uniform screening protocols are not inherently criminal, but prosecutors characterize the repetition as a reimbursement-driven practice because insurers allegedly required medical necessity before covering diagnostic cardiovascular examinations administered to otherwise healthy student populations across the country.
The defense can argue that preventive testing offered genuine value, that standardized panels reflected a consistent safety protocol, or that coverage disputes and documentation failures should not be recast automatically as evidence of intentional federal fraud.
False Diagnoses Allegedly Converted Screening into Reimbursable Care
The indictment alleges that participants assigned false diagnosis codes, including hypertension or elevated blood pressure, to information gathered through student questionnaires so that broad screening services would appear to insurers as individualized diagnostic care eligible for payment.
That accusation will depend upon patient-level records showing what each athlete reported, which measurements were collected, who selected each code, what payer rules applied, and whether Finkelstein understood allegedly false information appearing within claims submitted through his companies.
Commercial plans, the Federal Employees Health Benefits Program, the Veterans Health Administration, and Medicaid were identified as alleged payers, making this a mixed public-and-private insurance case rather than a prosecution centered upon traditional Medicare reimbursement.
Claims also allegedly placed services at Finkelstein’s Texas office even though tests occurred on distant campuses, potentially affecting rules governing professional participation, location, supervision, credentials, network status, payment eligibility, and reimbursement under different benefit plans.
The defense may seek evidence that billing software populated locations automatically, administrative employees selected disputed codes, insurers possessed accurate campus information elsewhere, or any incorrect field lacked the material importance necessary to support a criminal conviction.
The Alleged Financial Scale Raises the Stakes
Prosecutors say more than $89 million in false claims were submitted and more than $13.1 million was paid into accounts associated with Finkelstein’s professional entities, while approximately $1.1 million allegedly reached him through checks and wires during the charged period.
Those numbers represent different legal and accounting concepts, because submitted charges, payer reimbursements, personal compensation, forfeitable proceeds, intended loss, actual loss, restitution, and legitimate service value are not interchangeable measures of criminal responsibility for any defendant.
The indictment seeks forfeiture of approximately $13.1 million and identifies substitute-asset procedures, but forfeiture allegations remain contingent upon conviction and proof rather than establishing that the requested amount is presently owed or judicially established.
Financial experts may be asked to separate valid services from challenged transactions, trace deposits among related companies, review denied claims and appeals, compare insurer policies, and determine which payments can be connected reliably with conduct alleged against the defendant.
For jurors, the central question will not be whether the aggregate numbers appear impressive, but whether the government proves that Finkelstein knowingly participated in material deception tied to the specific criminal counts before them.
Electronic Approval Records May Become Essential Trial Evidence
The government alleges Finkelstein routinely signed cardiovascular results as normal within only seconds of accessing them electronically, even when the underlying studies contained numerous images and preliminary information that prosecutors say required meaningful professional evaluation.
Those timestamps could connect the clinical and financial sides of the case because a physician’s signature allegedly reassured athletes about their health while supporting claims representing that an appropriate professional interpretation had been completed for reimbursement.
Technical experts may examine audit-log design, clock synchronization, user authentication, automated status changes, shared credentials, report templates, system migrations, and whether recorded platform activity captures every stage of image review and final signature with sufficient historical accuracy.
The defense may contend that Finkelstein reviewed studies before the recorded access event, used another interface, relied on preliminary readers, evaluated composite reports, or completed relevant analysis outside the limited activity captured in exported platform logs.
Prosecutors can respond by comparing thousands of recorded intervals with image volume, study complexity, report language, witness testimony, messages, and later claims, seeking a repeated pattern too consistent to be explained by occasional technical limitations.
Digital evidence can look decisive because it records precise times, yet jurors will need expert context before concluding what any timestamp proves about medical attention, authorship, workflow, intent, or the completeness of a historical data export.
Medical Experts Will Address Necessity and Interpretation
Cardiology experts may explain what information a physician ordinarily needs before ordering diagnostic tests, how long responsible interpretation may require, which preliminary findings demand escalation, and whether reported normal results were clinically defensible under the available evidence.
Other specialists may address credentialing rules for sonographers, differences among screening and diagnostic services, standards governing remote interpretation, and the significance of conducting substantially identical panels across athletes with different medical histories and risk profiles.
Payer experts can explain coverage language and materiality, including whether an accurate diagnosis, service location, ordering-provider relationship, or reviewing-provider representation would have changed the benefit program’s decision to authorize, deny, or pay the disputed claim.
The defense can use competing experts to argue that clinical judgment permits disagreement, standardized screening retains preventive value, preliminary annotations are not final diagnoses, and administrative irregularities do not prove a deliberate agreement to defraud insurers.
Jurors must therefore separate disputed medicine, professional negligence, weak supervision, and billing mistakes from knowing criminal deception, a distinction that will likely define the most important testimony presented during the scheduled West Palm Beach trial.
One Athlete’s Death Gives the Case Exceptional Human Weight
The indictment describes approximately 63 images from an October 2024 examination of one student athlete, some carrying unconfirmed preliminary references to possible right-sided heart enlargement before Finkelstein allegedly signed the entire collection as normal without qualification.
Prosecutors allege he approved the images approximately eleven seconds after accessing them, and the athlete died from sudden cardiac arrest approximately twenty-four days later, creating an emotionally powerful episode likely to receive careful evidentiary attention.
Reporting by The Associated Press described the prosecution as part of a national healthcare-fraud crackdown while emphasizing the government’s assertion that Finkelstein approved unnecessary athlete tests without personally reviewing the underlying results, according to prosecutors.
The athlete’s death does not independently establish fraudulent intent, medical causation, or criminal responsibility, and the defense may challenge the preliminary notations, timing evidence, cause of death, relevance of disputed findings, and relationship between the screening and later collapse.
Prosecutors may nevertheless argue that continued rapid approvals after Finkelstein learned about the death and the athlete’s mother’s concerns illuminate knowledge, intent, and the alleged gap between lifesaving marketing promises and actual professional review at trial.
Pretrial Litigation Will Shape What Jurors Hear
During the months before April 2027, lawyers may litigate the admissibility of electronic records, expert opinions, patient information, business communications, financial evidence, alleged referral payments, and testimony concerning events outside the three substantive claims that prosecutors may introduce at trial.
Defense motions could challenge whether broader allegations create unfair prejudice, while prosecutors may argue that recurring conduct supplies necessary context for understanding the alleged conspiracy, proving knowledge, explaining corporate relationships, and interpreting otherwise isolated transactions.
The court may also address confidentiality and privacy protections because medical records involving student athletes can contain sensitive personal information even when public filings use initials or other measures intended to limit unnecessary identification during proceedings.
Discovery across numerous schools and payers could raise disputes about completeness, authentication, privilege, search methods, lost records, expert access, or deadlines, any of which might affect whether the current trial date remains workable for everyone involved.
The September status conference offers the next public opportunity for the court to assess those preparations, although many discovery exchanges and strategic decisions will occur outside the courtroom under established criminal procedure before trial begins.
The Government Still Bears the Entire Burden of Proof
An indictment records accusations approved for prosecution by a grand jury, but it is not evidence of guilt and cannot replace testimony, authenticated documents, expert analysis, cross-examination, judicial instructions, and deliberation by an impartial trial jury.
For conspiracy, prosecutors must prove Finkelstein knowingly joined the charged agreement with the required criminal purpose, while mere association, ownership, medical-director status, compensation, or participation in an imperfect business operation cannot establish guilt on its own.
For substantive healthcare fraud, the government must connect Finkelstein with identified executions or attempted executions involving materially false representations, healthcare benefit programs, knowing conduct, and the delivery or payment of covered items or services under federal law.
The wire-fraud objective adds questions about intentional deception and interstate communications used to execute the alleged plan, although the precise legal standards presented to jurors will come through Judge Cannon’s final instructions after evidence closes.
If the evidence leaves reasonable doubt about intent, attribution, materiality, or participation, the jury must acquit regardless of whether it believes medical care was careless, corporate oversight was poor, or insurer documentation was inaccurate.
The Defense Has Several Paths for Contesting the Narrative
Defense lawyers may separate Finkelstein’s medical role from marketing, intake, coding, billing, referral arrangements, software administration, corporate restructuring, and claim appeals handled by other participants across a geographically dispersed operation, arguing that federal law requires proof connecting him personally to the alleged deception.
They may argue that employees selected diagnoses or locations without his knowledge, that electronic systems failed to capture genuine review, that reimbursement rules varied, or that services retained value despite documentation problems and contested coverage.
The defense can also test the reliability and motives of cooperating witnesses, examine complete message threads instead of isolated excerpts, challenge statistical sampling, and demand proof linking each charged claim with Finkelstein’s personal knowledge and actions.
Corporate ownership and receipt of money may support a prosecution inference, yet lawful compensation for professional work does not become fraudulent proceeds unless the government first establishes the underlying deception and the defendant’s knowing participation.
Prosecutors will likely respond with evidence of repetition, rapid approvals, internal communications, false diagnoses, disputed service locations, payer appeals, multistate licensing, continuing payments, and alleged efforts to circumvent insurer controls through additional companies.
The trial may therefore become a contest between an integrated government narrative and a defense strategy that divides clinical, technical, administrative, and financial events among different people whose responsibilities cannot be automatically attributed to one physician.
Schools and Insurers Will Watch the Trial Closely
College administrators may view the evidence as a practical warning to verify vendor credentials, ordering practices, billing arrangements, referral compensation, consent procedures, result-review systems, emergency escalation, and who is responsible for communicating potentially dangerous findings to students.
Athletes should receive clear explanations about whether testing is optional, whether insurance will be billed, which diagnoses may enter their records, who reviews images, and what follow-up becomes available when a screening identifies a possible abnormality.
Insurers can examine repeated test bundles, identical diagnostic codes, unusual service locations, exceptionally brief approval intervals, concentrated campus dates, high-volume ordering physicians, and questionable appeals without treating statistical anomalies as automatic proof of fraud on their own.
The case also shows why a service marketed as free can still carry significant financial consequences: the absence of a direct student payment does not mean an insurer or public benefit program receives no claim.
Regardless of the verdict, evidence presented at trial may influence compliance reviews throughout sports medicine, remote diagnostics, campus health partnerships, credential verification, and the increasingly automated systems used to document professional interpretations and submit claims.
Public Communication Must Follow the Court Record
Healthcare organizations confronting comparable allegations need disciplined communication that informs patients, employees, partner schools, insurers, regulators, and reporters without exposing protected records, influencing witnesses, contradicting counsel, or presenting unresolved accusations as established facts before trial.
Amicus International Consulting’s crisis public relations guidance emphasizes structured assessment and consistent messaging, principles that can support responsible communication during litigation while legal counsel manages evidence, confidentiality, procedural obligations, and courtroom strategy throughout the proceeding.
Its framework for rebuilding a damaged public reputation likewise recognizes that durable recovery depends upon accurate, verifiable information, although ethical reputation work cannot erase authentic court records, manufacture exoneration, suppress legitimate reporting, or substitute publicity for accountability.
Schools connected with a questioned vendor should explain what they knew, whether referrals or compensation occurred, how they will contact students, and which independent clinical or billing reviews will protect affected communities without prejudging the criminal case.
Responsible news coverage should identify every disputed act as an allegation, distinguish the $89 million billed from the $13.1 million allegedly paid, avoid describing this as a traditional Medicare case, and prominently preserve Finkelstein’s presumption of innocence.
April 2027 Is the Current Date, not a Guaranteed Outcome
The published schedule gives lawyers, witnesses, institutions, and the public a meaningful horizon, but later motions, discovery developments, judicial conflicts, negotiated resolutions, or other lawful circumstances could move or eliminate the April 5 trial through a later order.
Until the court issues a different order, the case remains positioned for a West Palm Beach jury to examine whether school-based cardiovascular screening became the foundation for intentional insurance deception or reflected a complicated operation whose failures did not constitute federal crimes.
The prosecution will ask jurors to connect marketing, testing volume, false diagnoses, electronic approvals, corporate billing, interstate transmissions, and payments into one knowing scheme, while the defense will demand that every link be proved with reliable, admissible evidence.
For student athletes and their families, the trial’s significance extends beyond reimbursement because the allegations concern whether medical assurances offered in the language of safety were supported by the careful professional attention those assurances naturally implied.
Jason Finkelstein remains presumed innocent as the September status conference approaches, and the scheduled April 2027 proceeding offers an opportunity to test competing accounts publicly under rules designed to protect both accountability and due process.
